Versant Venture Management, LLC - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,100,000
-25.9%
1,000,0000.0%2.53%
-7.4%
Q2 2021$8,230,000
-29.8%
1,000,000
-23.7%
2.73%
+19.3%
Q1 2021$11,726,000
-73.6%
1,310,169
-65.9%
2.28%
-50.4%
Q4 2020$44,343,000
+10.9%
3,842,5780.0%4.60%
-37.1%
Q3 2020$40,001,0003,842,5787.32%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,842,578$40,001,0007.32%
MILLER VALUE PARTNERS, LLC 5,274,439$54,907,0001.97%
Mesirow Financial Investment Management, Inc. 32,371$337,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,068,580$11,124,0001.25%
Clearline Capital LP 399,159$4,155,0001.09%
CLOUGH CAPITAL PARTNERS L P 1,246,150$12,972,0000.93%
Novo Holdings A/S 1,403,370$14,609,0000.72%
SNOW CAPITAL MANAGEMENT LP 303,265$3,157,0000.63%
AMERICAN FINANCIAL GROUP INC 317,700$3,308,0000.46%
Granahan Investment Management 1,257,690$13,093,0000.44%
View complete list of FLEXION THERAPEUTICS INC shareholders